Skip to Content

Join the 'Autoimmune Hepatitis' group to help and get support from people like you.

Autoimmune Hepatitis News

Groundbreaking Partnership Formed to Develop New Treatments

Posted 4 Feb 2014 by Drugs.com

TUESDAY, Feb. 4, 2014 – In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating common chronic diseases. The first diseases targeted by the Accelerating Medicines Partnership are Alzheimer's, type 2 diabetes and two autoimmune disorders, rheumatoid arthritis and lupus. The partnership will invest more than $230 million over five years on these initial projects. The data and analyses that result will be made available to all biomedical researchers, the NIH said. "Patients and their caregivers are relying on science to find better and faster ways to detect and treat disease and improve their quality of life," NIH director Dr. Francis Collins said in an agency news release. "Currently, we are investing a great deal of money and time in ... Read more

Related support groups: Diabetes, Type 2, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Alzheimer's Disease, Lupus Erythematosus, Autoimmune Hepatitis

Ask a Question

Further Information

Related Condition Support Groups

Idiopathic Immune Hepatitis, Autoimmune Disorders

Related Drug Support Groups

Imuran, budesonide, azathioprine, mercaptopurine, mycophenolate mofetil, Purinethol, Azasan